Dishman’s Netherlands Site Completes FDA Inspection

Dishman Group has successfully completed an inspection by the U.S. FDA for its Netherlands site, confirming the site is compliant with cGMP principles and guidelines. Dishman Netherlands, located in Veenendaal, sells and manufactures Vitamin D analogues, Vitamin D, Cholesterol and lanolin related products for pharmaceutical, cosmetic, food, feed and industry applications, and is equipped with a full cGMP production lab.

“This success is the result of great team work. I would like to express my thanks to my staff. The entire team contributed to this successful inspection and I’m very proud of them,”commented Mark Ipema, vice president operations, Dishman Netherlands. “The result we have achieved is of great importance not only to Dishman Netherlands, but also to the entire Dishman Group, demonstrating our commitment to meeting and exceeding customer requirements.”